Page 7 - Ichnos Sciences News Today

/PRNewswire/ -- Century Therapeutics, a leading cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology,...

Mumbai (Maharashtra) [India], May 31 (ANI/PRNewswire): EBITDA growth of 22.7 per cent to Rs 20,844 Mn with margins of 19 per cent. Consolidated Net Profit of Rs 9,701 Mn with growth of 25 per cent in FY21.

Share this article Share this article NEW YORK, May 21, 2021 /PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology and autoimmune diseases, today announced that Alessandro Riva, M.D., will be leaving Ichnos effective August 15, 2021. We want to thank Dr. Riva for his visionary leadership as the first CEO of Ichnos. His strategic and scientific drive have given Ichnos a solid foundation to create and develop new medicines for ...

Share this article Share this article NEW YORK, April 5, 2021 /PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology and autoimmune diseases, today announced the appointment of Cyril Konto, M.D., to the new position of Chief Medical Officer (CMO), effective immediately. Dr. Konto, who reports to Chief Executive Officer Alessandro Riva, M.D., will oversee oncology clinical sciences, clinical operations, regulatory sciences, dru...

Share this article Share this article NEW YORK, March 2, 2021 /PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology and autoimmune diseases, today named Michael D. Price as Chief Financial Officer (CFO), effective immediately. Michael Price, formerly executive vice president and CFO at Akcea Therapeutics and a certified public accountant, is an experienced biotech financial professional, having served as a CFO of four such co...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Ichnos Sciences To Present At 39th Annual J.P. Morgan Healthcare Conference January 14, 2021 GMT (PRNewsfoto/Ichnos Sciences) NEW YORK, Jan. 14, 2021 /PRNewswire/ -- Ichnos Sciences Inc., a fully integrated, global biotechnology company developing potentially transformative biologic therapies that harness the immune system to treat cancer, is pleased to announce that Alessandro Riva, M.D., Chief Executiv...